Engagements across five geographies and four sectors. Client identities are anonymized, consistent with our confidentiality commitments. This list is not exhaustive.
| Engagement | Sector | Geography | Client Type |
|---|---|---|---|
| Commercial due diligence, API manufacturing plant | API | KSA | Global PE giant |
| Technical feasibility & NPV/IRR analysis, API plant | API | KSA | Global PE giant |
| Market sizing & molecule shortlisting, generics | Formulation | India | Diversified global PE |
| Sales force deployment benchmarking | Distribution | US/EU | MNC pharma company |
| Brand monitoring & marketing intelligence | Distribution | India | MNC pharma company |
| Generic drug launch tracking, 18-month program | Formulation | Global | Innovator pharma company |
| Customer & procurement analysis, CDMO/CMO segment | API | India | Investment firm |
| Vendor-selection criteria study, generic majors | API | India | Investment firm |
| Diagnostics market feasibility study | Diagnostics | India | Consulting firm client |
| Distribution channel diligence | Distribution | India | Consulting firm client |
| Power BI sales dashboard build | Distribution | India | MNC pharma company |
| API pricing & competitive-intensity study | API | KSA | Global PE giant |
| Formulation plant business-plan & capex review | Formulation | India | Diversified global PE |
| HCP prescription behaviour tracking | Distribution | India | MNC pharma company |
| Sales force deployment, EU expansion | Distribution | US/EU | MNC pharma company |
| Diagnostics competitive landscape mapping | Diagnostics | Global | Investment firm |
| API demand forecasting & segment sizing | API | KSA | Global PE giant |
| Generic launch readiness, biosimilar segment | Formulation | Global | Innovator pharma company |
| Distribution partner due diligence | Distribution | India | Consulting firm client |
| Diagnostics regulatory & market entry study | Diagnostics | India | Investment firm |
| API manufacturing NPV/IRR scenario analysis | API | KSA | Global PE giant |
| Formulation company customer segmentation | Formulation | India | Diversified global PE |
| Sales force salary & incentive benchmarking | Distribution | India | MNC pharma company |
| Marketing spend reconstruction, chronic therapy brand | Distribution | India | MNC pharma company |
| Diagnostics vendor-selection study | Diagnostics | India | Consulting firm client |
| API plant technical feasibility, sterile segment | API | KSA | Global PE giant |
| Formulation generic pipeline tracking | Formulation | Global | Innovator pharma company |
| Distribution margin & trade-scheme analysis | Distribution | India | MNC pharma company |
| Power BI sales-force deployment dashboard | Distribution | India | MNC pharma company |
| API business plan & working-capital estimate | API | KSA | Global PE giant |
| Diagnostics competitive intelligence, HCP channel | Diagnostics | India | Investment firm |
SI-Insights